6 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Novel immunotherapies for type 1 diabetes (NAIMIT)
Date du début: 1 nov. 2009, Date de fin: 30 avr. 2015,
This proposal will pioneer the concept of tailored interventions with minimal immune system interference in new onset T1DM, leading to beta-cell protection and restoration, based on a solid understanding of the disease pathogenesis. This will enable experimental findings to be adopted for future clinical application. Four work packages are grouped around ‘Reversal of autoimmunity’, in which two ke ...
Voir le projet
15
Participants partenaires
TERMINÉ
Learning from International Networks about Errors and Understanding Safety in Primary Care (LINNEAUS EURO -PC)
Date du début: 1 mars 2009, Date de fin: 31 mai 2013,
There is a deficit in activity related to patient safety in primary care and the primary care/secondary care interface in Europe. This deficit relates to research, to sharing of information, to learning and to collaboration.This co-ordination action will specifically address issues addressed in the call through: (1)The development of a taxonomy of adverse events and errors. (2) Identifying best cl ...
Voir le projet
12
Participants partenaires
TERMINÉ
Angiogenesis-inducing Bioactive and Bioresponsive Scaffolds in Tissue Enginering (AngioScaff)
Date du début: 1 déc. 2008, Date de fin: 30 nov. 2012,
Angiogenesis underlies almost all biological processes of morphogenesis, including those in tissue repair and regeneration. Physiological angiogenesis is controlled by a complex interplay between cells and their environment: the extracellular matrix (ECM) provides signaling via numerous ECM adhesion molecules and growth factors bound to ECM polysaccharide components; and cells locally degrade and ...
Voir le projet
33
Participants partenaires
TERMINÉ
Pathophysiology and natural course of autoimmune adrenal failure in Europe (Euradrenal)
Date du début: 1 avr. 2008, Date de fin: 31 mars 2012,
Autoimmune Addison’s disease (AAD) is an endocrine disease resulting from the immune system’s destruction of hormone producing cells in the adrenal cortex. Diagnosis is frequently first established after a life-threatening adrenal crisis, often resulting in untimely fatalities. The disease is rare, more common in women than in men, and also affects children. AAD very frequently occurs with other a ...
Voir le projet
12
Participants partenaires
TERMINÉ
Developing and validating disease management evaluation methods for European health care systems (DISMEVAL)
Date du début: 1 janv. 2009, Date de fin: 31 déc. 2011,
Chronic health conditions that impose a heavy burden on society and account for a large share of health care costs. Better prevention and management could potentially decrease costs and improve quality of care and health outcomes. An important means of accomplishing these goals is through the use of disease management (DM) interventions that educate patients about prevention and health management ...
Voir le projet
10
Participants partenaires
TERMINÉ
"European Networks of Centres of Expertise for CF (Cystic Fibrosis), LAM (Lymphangioleiomyomatosis), and LTX (Lung Transplantation)" (ENCE-CF-LAM-LTX)
Date du début: 1 avr. 2009, Date de fin: 31 mars 2011,
"European Centres of Expertise Networks for rare diseases have been identified by the European Commission as one important area of future activity in the attempt of achieving one of the main objectives across the EC endeavour of “Optimising the delivery of health care to European Citizens”. It is obvious that especially in rare diseases the joined forces of the experts networking throughout Europe ...
Voir le projet